Skip to main content
Clinical Trials/NCT03746470
NCT03746470
Completed
Not Applicable

A Randomized Controlled Trial to Evaluate the Graft Ligamentization and Integration in the Reconstruction of the Anterior Cruciate Ligament With or Without Detachment of Hamstring Tendon Tibial Insertion

Ente Ospedaliero Cantonale, Bellinzona2 sites in 2 countries85 target enrollmentOctober 22, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Complete Tear, Knee, Anterior Cruciate Ligament
Sponsor
Ente Ospedaliero Cantonale, Bellinzona
Enrollment
85
Locations
2
Primary Endpoint
Graft integration by the Signal / Noise Quotient (SNQ) at 6 months
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

This is a prospective and randomized trial to compare two different techniques used in normal practice for the reconstruction of the anterior cruciate ligament in arthroscopy.

The experimental group (group 1) will undergo a reconstruction technique where semitendinosus and gracilis will preserve their insertion at the level of the hamstring whereas in the control group (group 2) the semitendinosus and gracilis tendons will be disengaged from their insertion on the hamstring .

Registry
clinicaltrials.gov
Start Date
October 22, 2018
End Date
September 29, 2024
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ente Ospedaliero Cantonale, Bellinzona
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age between 18 and 55
  • MRI confirmed primary and total ACL injury of traumatic origin
  • Indication for ACL reconstruction in arthroscopy
  • Written informed consent
  • Active and non-sedentary lifestyle

Exclusion Criteria

  • Complex meniscal injuries
  • Cartilage lesions of sizes\> 2 cm2
  • Other ligamentous lesions
  • Axis deviations greater than 10°
  • Rheumatic, neuromuscular or general systemic diseases
  • Prevention of injured knee traumas treated surgically
  • Difficulties in compliance in following the rehabilitation programs
  • Obesity (BMI ≥ 30)
  • Neoplastic diseases, metabolic diseases, inflammatory and systemic diseases, autoimmune diseases, immunocompromised patients

Outcomes

Primary Outcomes

Graft integration by the Signal / Noise Quotient (SNQ) at 6 months

Time Frame: 6 months after ACL reconstruction intervention

Signal intensity of the graft evaluated by the Signal / Noise Quotient (SNQ) during MRI 3 Tesla

Secondary Outcomes

  • Graft integration by the Signal / Noise Quotient (SNQ) at 3 and 12 months(3, 12 months after ACL reconstruction intervention)
  • Right anatomical graft position(12 months after ACL reconstruction intervention)
  • Anterior tibial translation(3, 6, 12 months after ACL reconstruction intervention)
  • Anterior knee joint instability(3, 6, 12 months after ACL reconstruction intervention)
  • IKDC (International Knee Documentation Committee) questionnaire(3, 6, 12 months after ACL reconstruction intervention)
  • Tegner activity scale(3, 6, 12 months after ACL reconstruction intervention)

Study Sites (2)

Loading locations...

Similar Trials